| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |